A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop)

被引:47
作者
Langdown, Jonathan [1 ]
Luddington, Roger J. [1 ]
Huntington, James A. [2 ]
Baglin, Trevor P. [1 ]
机构
[1] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Haemophilia & Thrombophilia Ctr, Addenbrookes Hosp, Cambridge CB20QQ, England
[2] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England
基金
英国惠康基金;
关键词
PROTEIN-C ANTICOAGULANT; THROMBIN-ACTIVATABLE FIBRINOLYSIS; POLYMORPHISM; COAGULATION; INHIBITOR; COMPLEX; TAFI;
D O I
10.1182/blood-2014-02-557538
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study, we describe a novel thrombomodulin (TM) mutation (c. 1611C>A) that codes for a change from cysteine 537 to a premature stop codon (p.Cys537Stop). Three members of a family with a history of posttraumatic bleeding were identified to be heterozygous for this TM mutation. All coagulation screening tests, coagulation factor assays, and platelet function test results were within normal limits. However, the endogenous thrombin potential was markedly reduced at low-tissue factor concentration, and failure to correct with normal plasma indicated the presence of a coagulation inhibitor. Plasma TM levels were highly elevated (433-845 ng/ml, normal range 2-8 ng/ml, equating to 5 to 10 nM), and the addition of exogenous protein C further decreased thrombin generation. The mutation, p.Cys537Stop, results in a truncation within the carboxyl-terminal transmembrane helix. We predict that as a consequence of the truncation, the variant TM is shed from the endothelial surface into the blood plasma. This would promote systemic protein C activation and early cessation of thrombin generation within a developing hemostatic clot, thereby explaining the phenotype of posttraumatic bleeding observed within this family.
引用
收藏
页码:1951 / 1956
页数:6
相关论文
共 24 条
[1]   Thrombin-cofactor interactions - Structural insights into regulatory mechanisms [J].
Adams, Ty E. ;
Huntington, James A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) :1738-1745
[2]  
Aleksic N, 2003, J THROMB HAEMOST, V1, P88
[3]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[4]   The central role of thrombin in hemostasis [J].
Crawley, J. T. B. ;
Zanardelli, S. ;
Chion, C. K. N. K. ;
Lane, D. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :95-101
[5]   Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study [J].
Dargaud, Yesim ;
Wolberg, Alisa S. ;
Luddington, Roger ;
Regnault, Veronique ;
Spronk, Henri ;
Baglin, Trevor ;
Lecompte, Thomas ;
Ten Cate, Hugo ;
Negrier, Claude .
THROMBOSIS RESEARCH, 2012, 130 (06) :929-934
[6]   Mechanisms of platelet activation by thrombin: A short history [J].
De Candia, Erica .
THROMBOSIS RESEARCH, 2012, 129 (03) :250-256
[7]   Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome [J].
Delvaeye, Mieke ;
Noris, Marina ;
De Vriese, Astrid ;
Esmon, Charles T. ;
Esmon, Naomi L. ;
Ferrell, Gary ;
Del-Favero, Jurgen ;
Plaisance, Stephane ;
Claes, Bart ;
Lambrechts, Diether ;
Zoja, Carla ;
Remuzzi, Giuseppe ;
Conway, Edward M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (04) :345-357
[8]   Inflammation and the activated protein C anticoagulant pathway [J].
Esmon, Charles T. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 :49-60
[9]   Protein C anticoagulant system-anti-inflammatory effects [J].
Esmon, Charles T. .
SEMINARS IN IMMUNOPATHOLOGY, 2012, 34 (01) :127-132
[10]  
ESMON CT, 1982, J BIOL CHEM, V257, P7944